Paper9687989
Mutational analysis of the TrkA gene in prostate cancer.
George DJ and 3 others. Prostate, 1998. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Mutational analysis of the TrkA gene in prostate cancer. Papers, record 9687989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9687989
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mutation | Major topic |
| Nerve Growth Factors | Major topic |
| Polymorphism, Single-Stranded Conformational | Major topic |
| Prostatic Neoplasms | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Nerve Growth Factor | Major topic |
| Amino Acid Sequence | |
| DNA Mutational Analysis | |
| DNA Primers | |
| Humans | |
| Male | |
| Molecular Sequence Data | |
| Receptor, trkA |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41742295 | NGF-mediated tumor-stroma crosstalk promotes prostate cancer aggressiveness. | J Transl Med | 2026 | https://conductscience.org/library/papers/41742295 | PubMed |
| 34268306 | Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34268306 | PubMed |
| 31937919 | Tumour innervation and neurosignalling in prostate cancer. | Nat Rev Urol | 2020 | https://conductscience.org/library/papers/31937919 | PubMed |
| 31527385 | Mouse Nerve Growth Factor Facilitates the Growth of Interspinal Schwannoma Cells by Activating NGF Receptors. | J Korean Neurosurg Soc | 2019 | https://conductscience.org/library/papers/31527385 | PubMed |
| 31174415 | Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31174415 | PubMed |
| 30533196 | Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors. | Oncotarget | 2018 | https://conductscience.org/library/papers/30533196 | PubMed |
| 29914559 | The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29914559 | PubMed |
| 29715200 | TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29715200 | PubMed |
| 29666826 | Dr. Coffey's visionary contributions to urological research in China and Japan. | Am J Clin Exp Urol | 2018 | https://conductscience.org/library/papers/29666826 | PubMed |
| 25394774 | TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. | Cancer Chemother Pharmacol | 2015 | https://conductscience.org/library/papers/25394774 | PubMed |
| 22623209 | AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts. | Cancer Chemother Pharmacol | 2012 | https://conductscience.org/library/papers/22623209 | PubMed |
| 20003389 | c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients. | BMC Cancer | 2009 | https://conductscience.org/library/papers/20003389 | PubMed |
| 19417027 | Trk receptor expression and inhibition in neuroblastomas. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19417027 | PubMed |
| 18795122 | TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma. | Transl Oncol | 2008 | https://conductscience.org/library/papers/18795122 | PubMed |
| 15870692 | Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression. | Oncogene | 2005 | https://conductscience.org/library/papers/15870692 | PubMed |
| 15528978 | Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor. | Invest New Drugs | 2005 | https://conductscience.org/library/papers/15528978 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 | NCBI Gene |
| NTRK1 | 4914 | PubTator's text mining | https://conductscience.org/library/genes/4914 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9687989
GET https://conductscience.org/api/papers/v1/9687989/authors